Stockreport

Cue Biopharma, Inc. (CUE) CEO Dan Passeri on Q3 2018 Results - Earnings Call Transcript [Seeking Alpha]

Cue Biopharma, Inc.  (CUE) 
US:NASDAQ Investor Relations: cuebiopharma.gcs-web.com/news-releases
PDF Cue Biopharma, Inc. (NASDAQ: CUE ) Q3 2018 Earnings Conference Call November 20, 2018 4:30 PM ET Executives John Woolford - Westwicke Partners Dan Passeri - [Read more]